{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:15:23Z","timestamp":1790626523761,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005356","name":"Zhejiang Shuren University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cytogfr.2026.01.008","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:08:00Z","timestamp":1770253680000},"page":"108-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cytokine storm divergence in viral infections of the upper respiratory tract"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-0991","authenticated-orcid":false,"given":"Keda","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/07380577.2017.1340690","article-title":"Occupational therapy in the intensive care unit: a systematic review","volume":"31","author":"Weinreich","year":"2017","journal-title":"Occup. Ther. Health care"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.008_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038356","article-title":"Human influenza epidemiology","volume":"11","author":"Ryu","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s44411-024-00010-7","article-title":"Comparative study of cytokine profiles in SARS-CoV-2 delta and Omicron variants","volume":"126","author":"Krivosova","year":"2025","journal-title":"Bratisl. Med. J."},{"issue":"23","key":"10.1016\/j.cytogfr.2026.01.008_bib4","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.008_bib5","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"Pt 1","key":"10.1016\/j.cytogfr.2026.01.008_bib6","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.008_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110501","article-title":"Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters","volume":"27","author":"Rajaiah","year":"2024","journal-title":"iScience"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.008_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v13122478","article-title":"Immunopathology of RSV: an updated review","volume":"13","author":"Bergeron","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2026.01.008_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.008_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.cytogfr.2026.01.008_bib13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.666223","article-title":"Profile of circulatory cytokines and chemokines in human coronaviruses: a systematic review and meta-analysis","volume":"12","author":"Zawawi","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.008_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biology9090280","article-title":"Factors associated with increased morbidity and mortality of obese and overweight COVID-19 patients","volume":"9","author":"Magdy Beshbishy","year":"2020","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib18","article-title":"Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies","volume":"10","author":"Guo","year":"2022","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7150\/ijbs.59272","article-title":"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy","volume":"18","author":"Jiang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib23","article-title":"Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: a Chinese herbal medicine repurposed for COVID-19 pandemic","volume":"1","author":"Liang","year":"2021","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"Pt B","key":"10.1016\/j.cytogfr.2026.01.008_bib25","article-title":"The triumvirate of NF-\u03baB, inflammation and cytokine storm in COVID-19","volume":"101","author":"Attiq","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.008_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.008_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095283","article-title":"The role of nuclear factor kappa B (NF-kappaB) in development and treatment of COVID-19: review","volume":"23","author":"Gudowska-Sawczuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib29","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.7150\/ijbs.95894","article-title":"mTOR signaling: roles in hepatitis B virus infection and hepatocellular carcinoma","volume":"20","author":"Mei","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation, The","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"36","key":"10.1016\/j.cytogfr.2026.01.008_bib32","article-title":"A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022","volume":"28","author":"Nyberg","year":"2023","journal-title":"Eur. Surveill. Bull. Eur. sur Les. Mal. Transm. = Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690477","article-title":"The many faces of JAKs and STATs within the COVID-19 storm","volume":"12","author":"Grant","year":"2021","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.cytogfr.2026.01.008_bib34","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.008_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126211","article-title":"Role of JAK\/STAT in interstitial lung diseases; molecular and cellular mechanisms","volume":"22","author":"Montero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story","volume":"83","author":"Bonelli","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.008_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/jmv.26009","article-title":"Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines","volume":"92","author":"Zheng","year":"2020","journal-title":"J. Med Virol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib38","first-page":"11","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib39","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/s41467-020-20412-9","article-title":"Author correction: imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology","volume":"11","author":"Molinaro","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib40","article-title":"Defining patient-level molecular heterogeneity in psoriasis vulgaris based on single-cell transcriptomics","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451145","article-title":"Immune signature of patients with cardiovascular disease predicts increased risk for a severe course of COVID-19","volume":"54","author":"G\u00fcnter","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib42","article-title":"Specific cytokine profiles predict the severity of influenza a pneumonia: a prospectively multicenter pilot study","author":"Xie","year":"2021","journal-title":"BioMed. Res. Int. 2021"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib43","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1038\/s41467-023-42432-x","article-title":"Obesity dysregulates the pulmonary antiviral immune response","volume":"14","author":"Almond","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.008_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"22","key":"10.1016\/j.cytogfr.2026.01.008_bib45","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","article-title":"Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement","volume":"83","author":"Welt","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.31083\/j.fbl2703105","article-title":"Oxidative stress-induced endothelial dysfunction in cardiovascular diseases","volume":"27","author":"Shaito","year":"2022","journal-title":"Front. Biosci. (Landmark Ed. )"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.008_bib47","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib49","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/jth.15509","article-title":"Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus","volume":"19","author":"Mackman","year":"2021","journal-title":"J. Thromb. Haemost. JTH"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.008_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2023.08.008","article-title":"Childhood respiratory viral infections and the microbiome","volume":"152","author":"Kloepfer","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"22","key":"10.1016\/j.cytogfr.2026.01.008_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214146","article-title":"Cytokine profiling in different SARS-CoV-2 genetic variants","volume":"23","author":"Korobova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib52","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jth.13307","article-title":"Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice","volume":"14","author":"Antoniak","year":"2016","journal-title":"J. Thromb. Haemost. JTH"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jth.14450","article-title":"Trauma-induced coagulopathy: the past, present, and future","volume":"17","author":"Kornblith","year":"2019","journal-title":"J. Thromb. Haemost. JTH"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.008_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41574-020-0364-6","article-title":"Obesity and impaired metabolic health in patients with COVID-19","volume":"16","author":"Stefan","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"19","key":"10.1016\/j.cytogfr.2026.01.008_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199715","article-title":"Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction","volume":"26","author":"Choi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/DMSO.S434115","article-title":"The impact of obesity on the host-pathogen interaction with influenza viruses - novel insights: narrative review","volume":"17","author":"Miron","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"172","key":"10.1016\/j.cytogfr.2026.01.008_bib57","article-title":"Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old","volume":"33","author":"Smits","year":"2024","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570251","article-title":"G.A. Mart\u00ednez-Nava, NLRP3 inflammasome: the stormy link between obesity and COVID-19","volume":"11","author":"L\u00f3pez-Reyes","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.008_bib59","first-page":"918","article-title":"Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up","volume":"29","author":"Barda","year":"2023","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"issue":"7918","key":"10.1016\/j.cytogfr.2026.01.008_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-022-04865-0","article-title":"Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination","volume":"607","author":"Suryawanshi","year":"2022","journal-title":"Nature"},{"issue":"7902","key":"10.1016\/j.cytogfr.2026.01.008_bib61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.01.008_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964525","article-title":"Breakthrough infections with the Omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity","volume":"13","author":"Soraas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib63","article-title":"Characterizing distinct profiles of immune and inflammatory response with age to Omicron infection","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s40001-023-01373-3","article-title":"Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity","volume":"28","author":"Thiruvengadam","year":"2023","journal-title":"Eur. J. Med Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13052-024-01836-1","article-title":"Immunological pathogenesis and treatment progress of adenovirus pneumonia in children","volume":"51","author":"Liang","year":"2025","journal-title":"Ital. J. Pediatr."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.008_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012556","article-title":"Exploring viral respiratory coinfections: shedding light on pathogen interactions","volume":"20","author":"Trepat","year":"2024","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.008_bib67","article-title":"Respiratory viral coinfections: insights into epidemiology, immune response, pathology, and clinical outcomes","volume":"13","author":"Babawale","year":"2024","journal-title":"Pathog. (Basel Switz. )"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.008_bib68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib69","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3389\/fimmu.2019.03102","article-title":"IL-6 during influenza-streptococcus pneumoniae co-infected pneumonia-a protector","volume":"10","author":"Gou","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/v16050793","article-title":"SARS-CoV-2 and influenza co-infection: fair competition or sinister combination?","volume":"16","author":"Teluguakula","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/22221751.2021.1884503","article-title":"COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue","volume":"10","author":"Yongzhi","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib72","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.23812\/20-1-E","article-title":"Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"19","key":"10.1016\/j.cytogfr.2026.01.008_bib73","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMe1212300","article-title":"Emerging human coronaviruses--disease potential and preparedness","volume":"367","author":"Anderson","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med Virol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib75","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.2147\/JIR.S329697","article-title":"Comparison of the characteristics of cytokine storm and immune response induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections","volume":"14","author":"Liu","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"50","key":"10.1016\/j.cytogfr.2026.01.008_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3024","article-title":"Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm","volume":"6","author":"Mudd","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.008_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob. Health"},{"issue":"10323","key":"10.1016\/j.cytogfr.2026.01.008_bib78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet (Lond. Engl. )"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.008_bib79","article-title":"Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options","volume":"12","author":"Pelle","year":"2022","journal-title":"Life (Basel Switz. )"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/biom15111545","article-title":"Expression patterns of interferons and proinflammatory cytokines in the upper respiratory tract of patients infected by different viral pathogens: correlation with age and viral load","volume":"15","author":"Ferrarese","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.008_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080948","article-title":"Inflammation: is it a healer, confounder, or a promoter of cardiometabolic risks?","volume":"14","author":"Tate","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.008_bib84","article-title":"Diabetes mellitus and pneumococcal pneumonia","volume":"14","author":"Cilloniz","year":"2024","journal-title":"Diagn. (Basel Switz. )"},{"key":"10.1016\/j.cytogfr.2026.01.008_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154164","article-title":"The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to the intensive care units","volume":"72","author":"Lee","year":"2022","journal-title":"J. Crit. care"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients","volume":"11","author":"Shafran","year":"2021","journal-title":"Sci. Rep."},{"issue":"Pt 12","key":"10.1016\/j.cytogfr.2026.01.008_bib87","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment","volume":"94","author":"Lau","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00165-13","article-title":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","volume":"4","author":"Josset","year":"2013","journal-title":"mBio"},{"issue":"7923","key":"10.1016\/j.cytogfr.2026.01.008_bib89","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.01.008_bib91","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1111\/bph.15865","article-title":"Review of delta-8-tetrahydrocannabinol (\u0394(8) -THC): comparative pharmacology with \u0394(9) -THC","volume":"179","author":"Tagen","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib92","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0885066618817518","article-title":"The role of inflammatory cytokines in cardiac arrest","volume":"35","author":"Jou","year":"2020","journal-title":"J. Intensive care Med."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: relevance for immunopathology of SARS-CoV-2","volume":"53","author":"Gubernatorova","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6504","key":"10.1016\/j.cytogfr.2026.01.008_bib94","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science (New York N. Y. )"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiac109","article-title":"The concept of classical herd immunity may not apply to COVID-19","volume":"226","author":"Morens","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.551413","article-title":"Adenovirus 7 induces interlukin-6 expression in human airway epithelial cells via p38\/NF-\u03baB signaling pathway","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","article-title":"Global pandemics interconnected - obesity, impaired metabolic health and COVID-19","volume":"17","author":"Stefan","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib98","article-title":"SARS-CoV-2 variants, vaccines, and host immunity","volume":"12","author":"Mistry","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib99","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12879-023-08132-z","article-title":"Comparisons of lymphocytes profiles and inflammatory cytokines levels in blood of patients with differed severity of infection by human adenovirus type 7","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33354","article-title":"IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib101","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","article-title":"Understanding the symptoms of the common cold and influenza","volume":"5","author":"Eccles","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jpids\/piaa075","article-title":"Severe acute respiratory syndrome coronavirus 2 infections in children: multicenter surveillance, United States, January-March 2020","volume":"9","author":"Rha","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/v16020308","article-title":"Beneficial and detrimental effects of cytokines during influenza and COVID-19","volume":"16","author":"Chang","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2026.01.008_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.770066","article-title":"Dysregulated inflammation during obesity: driving disease severity in influenza virus and SARS-CoV-2 Infections","volume":"12","author":"Hulme","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.008_bib106","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.008_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105240","article-title":"Adenovirus structure: what is new?","volume":"22","author":"Gallardo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib108","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bj.2021.08.009","article-title":"Human adenovirus infections in pediatric population - an update on clinico-pathologic correlation","volume":"45","author":"Shieh","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coviro.2021.03.006","article-title":"Adenovirus - a blueprint for gene delivery","volume":"48","author":"Greber","year":"2021","journal-title":"Curr. Opin. Virol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.008_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/v14050888","article-title":"Cytokine responses to adenovirus and adenovirus vectors","volume":"14","author":"Atasheva","year":"2022","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.008_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/v15101999","article-title":"Host responses to respiratory syncytial virus infection","volume":"15","author":"Agac","year":"2023","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib112","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.cytogfr.2026.01.008_bib113","article-title":"Cytokine storm","volume":"384","author":"Gaestel","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib114","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1038\/s41467-023-42421-0","article-title":"Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs","volume":"14","author":"Weeratunga","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-022-01021-1","article-title":"Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19","volume":"14","author":"Ma","year":"2022","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib116","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuae007","article-title":"In vitro modelling of bacterial pneumonia: a comparative analysis of widely applied complex cell culture models","volume":"48","author":"Mahieu","year":"2024","journal-title":"FEMS Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.008_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000624","article-title":"In Vitro models for studying respiratory host-pathogen interactions","volume":"5","author":"Barron","year":"2021","journal-title":"Adv. Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.008_bib118","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tips.2020.05.005","article-title":"In Vitro and animal models for SARS-CoV-2 research","volume":"41","author":"Takayama","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.008_bib119","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.18632\/aging.103255","article-title":"Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients","volume":"12","author":"Yang","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.008_bib120","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1038\/s41467-020-19080-6","article-title":"Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19","volume":"11","author":"Carissimo","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.01.008_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.008_bib122","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1093\/infdis\/jiaf290","article-title":"Genome-scale meta-analysis of host responses to staphylococcus aureus identifies pathways for host-directed therapeutic targeting","volume":"232","author":"Russell","year":"2025","journal-title":"J. Infect. Dis."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:01:34Z","timestamp":1774018894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961012600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":122,"alternative-id":["S135961012600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.008","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine storm divergence in viral infections of the upper respiratory tract","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}